Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.
about
Lupus Nephritis: A Different Disease in European Patients?Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease PhenotypeNon-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosusCardiorheumatology: cardiac involvement in systemic rheumatic diseaseNonsteroidal anti-inflammatory drugs in systemic lupus erythematosusLymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosusAutologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry.Urinary tract infections and lupus erythematosusOutcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus.Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.Suspects in the tale of lupus-associated thrombocytopenia.Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis.Acute presentation of thrombocytopaenia in systemic lupus erythematosus is associated with a high mortality in South Africa.Clinical features and outcome of pregnancy with SLE-associated thrombocytopenia.Prevalence of the American College of Rheumatology hematological classification criteria and associations with serological and clinical variables in 460 systemic lupus erythematosus patients.Thrombocytopenia in Systemic Lupus Erythematosus: Clinical Manifestations, Treatment, and Prognosis in 230 Patients.Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective studyRisk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institutionUnderstanding the epidemiology and progression of systemic lupus erythematosusPediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?Nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus.Therapy of systemic lupus erythematosus: new agents and new evidence.European Working Party on Systemic Lupus Erythematosus: a 10 year report.New classification criteria for systemic lupus erythematosus correlate with disease activityAbetimus sodium: a new therapy for delaying the time to, and reducing the incidence of, renal flare and/or major systemic lupus erythematosus flares in patients with systemic lupus erythematosus who have a history of renal disease.Lupus nephritis susceptibility loci in women with systemic lupus erythematosusConcurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus.Antiphospholipid syndrome: an overview.Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic featuresPathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideDefinition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy.Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients.Antiphospholipid antibody tests: spreading the netThe Diagnosis and Treatment of Systemic Lupus ErythematosusPrevalence of the American College of Rheumatology classification criteria in a group of 162 systemic lupus erythematosus patients from Croatia.Antiphospholipid (Hughes) syndrome.Prognostic factors in lupus nephritis.Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.
P2860
Q26740483-2D90983C-D5AC-4C3F-A6A3-5E95D7317186Q26769670-CCF20DC7-1E09-4FB3-B185-1BC746CC0CD5Q26796871-AA5638CF-CB89-419C-AE7F-2CFCE273CA84Q27008927-3ED1D5FE-C951-487B-95EC-2FAD4A1C9E53Q28182127-300D20FD-EDE1-48CD-A1D7-4A16A7E0B5C8Q28288186-6E6FCADB-DD25-43AB-B44D-6788B0EFF7CAQ30582614-BA0969B3-DD8F-4D5D-8DEF-63A6D8D27109Q33359987-30674A01-9885-48F3-9611-FA938FA8ABECQ33361803-680FD004-6190-4ACC-B48D-F8BCB0AFF5ABQ33363684-5078608C-5084-4139-A512-20E70551CABBQ33371650-5B42BA5D-47D6-44BC-A91A-6EAC20AAC84BQ33389368-78233086-F6F0-4B76-9EA1-BCE3B635714DQ33411369-BCA2533A-BD05-4FDB-A8BA-A892BB070B13Q33420949-EDD88C7A-F4E8-47B8-BBB5-81B84D6C8814Q33421528-CFFA9D09-1EF7-459D-882A-7BD0E0592255Q33429997-ADD5631B-CDD4-4237-BF79-76A71DB01410Q33437647-F472C1D2-A8C1-454D-82D9-6D9E864832ECQ33497970-52781EB4-7900-4B24-A837-3C419973AC4FQ33621131-36C50AA9-F1BD-465F-B4AC-D7EB742C85BDQ33723511-51699BFF-E0C9-4839-A880-699319A5923AQ34062871-442A07C7-C142-4F87-A6F7-2DBD8B37A4D0Q34074960-753CD135-B6C8-40A5-BA19-F6D525C18CF0Q34491073-66CBB730-EF19-4DB6-9EFB-45B95C1D6FFCQ34492782-FB617111-3E0D-4788-8036-0B9A42E88544Q34555048-0D8E7359-26AA-470C-B7D2-5801A875F3B6Q34568717-E6E4D1F2-29FB-4593-9C6A-592EB9709D58Q35031666-47211944-B893-4DBB-895B-132F814E5D90Q35099505-14D03E4F-A273-4EF2-BE5D-468077603E81Q35146181-58D6EB83-C7D4-4828-B246-A12D43D882E0Q35309470-CB050BFF-A430-4A51-9D09-98370A30A6CFQ35551137-AC3ACA6C-203D-4C91-AF4E-B3D419AE7238Q35552600-35E481AD-E263-422A-B6F0-61A98EBB222EQ35552703-B01EAF98-CC29-4597-A7AB-3E9D27221A37Q35553057-7312FAD2-814D-409F-9CF4-362CA37960E2Q35554909-7481DEFA-6F85-4919-B82B-6D41E65264F5Q35692998-C04DF11A-3817-4B26-BA89-4786689C19CCQ35929317-9975EBB3-C5EF-4563-93C7-34875D98D023Q35934717-4DD65472-064B-42BA-B7C3-3AE6210DB699Q36054839-F01D2DF5-AF70-4164-B1BA-E25F5F882DE8Q36084958-3544D78B-B8F1-4B93-A511-31272FAB8353
P2860
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@ast
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@en
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@nl
type
label
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@ast
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@en
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@nl
prefLabel
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@ast
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@en
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@nl
P2093
P50
P1433
P1476
Morbidity and mortality in sys ...... Systemic Lupus Erythematosus.
@en
P2093
Aydintug AO
Fernández-Nebro A
Houssiau F
Jedryka-Góral A
Sebastiani GD
de Ramón E
P304
P356
10.1097/00005792-199905000-00003
P407
P50
P577
1999-05-01T00:00:00Z